Clinical Trial: A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression

U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07485595) titled 'A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression' on March 16.

Brief Summary: The purpose of this study is to evaluate the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Depression

Intervention: DRUG: Placebo group

(2 of 50 mg JS1-1-01 placebo tablets+1 of 75 mg JS1-1-01 placebo tablets)/time, 2 times per day, administered postprandial, for 8 consecutive weeks.

DRUG: JS1-1-01 low-dose group

(2 of 50 mg JS1-1-01 placebo tablets+1 of 75 mg JS1-1-01 tablets)/time...